Strategic collaboration between Columbus and Epista Life Science enables the conservative Pharmaceutical Industry to move their ERP system to the cloud AND stay in control of quality.
Ballerup, 4 November 2020: Life Science companies are historically late adopters of new technology, due to the heavily regulated nature of the industry. Patient safety and product quality are priority one, which means they must continuously prove they are in control of their IT systems. Staying in control of ERP systems has always been a challenge for Life Science companies. And today the challenge is even greater, with cloud systems forcing patches and upgrades several times per year. It’s now exponentially more demanding to maintain the validated state of your ERP system after go-live.
With more than 30 years in the global digitalization industry and emphasis on a regulated market, Columbus has established a stable and comprehensive foundation of operational offerings by means of current, structured services making sure that cloud-based pharma solutions will remain validated.
Epista Life Science is dedicated to continuously improving regulatory compliance. Throughout their decade of growth, they have pioneered new methods to help Life Science companies take advantage of technological advances in IT while remaining efficient, in control and in compliance.
The result of the trinity between product (Microsoft Dynamics 365FO), offerings and services (Columbus) and quality assurance and validation (Epista Life Science), enables Life Science companies to pursue a cloud strategy that will keep them efficiently in control and future-proof their business.
“In recent years, we have successfully specialized in accommodating the increasingly high demand for continuous updates. Updates that especially Cloud environments require in order to streamline processes and procedures. In addition to world-class Change Control, Release Management Processes and Automated Testing Programs, Columbus is now able to deliver - in collaboration with Epista Life Science. GxP validation services around the individual future updates of Microsoft D365FO, securing effective and efficient decision making. Therefore, we have high expectations, and are very pleased about, our collaboration with Epista Life Science,” says Lasse Bruhn, Vice President, Customer Operations, Columbus A/S.
Klavs Esbjerg, CEO and founder of Epista Life Science states: “When Life Science companies consider a new ERP system, they naturally focus on the large and complex implementation project standing before them. In Epista’s extensive experience, we commonly see Life Science companies make a huge mistake here. All too often, they underestimate, or overlook altogether, the next phase in the system lifecycle – namely ongoing operations and maintenance. We’re excited about our collaboration with Columbus in this area, because we believe it will help us turn our client’s obstacles into real business opportunities - and finally take advantage of all the benefits that cloud ERP systems have to offer.
This strategic collaboration between Columbus and Epista will future-proof Life Science companies with ERP solutions which that can be scaled as products develop and the business grows.
Columbus is a global IT services and consulting company with more than 2,000 employees serving 5,000+ customers worldwide. Columbus helps ambitious companies transform, maximize and futureproof their business digitally. We are specialized within the industries retail, distribution, food and manufacturing. We offer a comprehensive solution portfolio with deep industry knowledge, extensive technology expertise and profound customer insight. Columbus has offices and partners all over the world and we can deliver our solutions and services locally – on a global scale. www.columbusglobal.com
Epista Life Science has a vision to continuously improve regulatory compliance in the Life Sciences. We are industry influencers, pioneering new compliance methodologies and technologies to eliminate compliance challenges for our clients. Founded in 2009, with four offices spread around Denmark, Sweden, and Germany, our team of 80+ subject-matter-experts have turned compliance obstacles into business opportunities for over 170 clients, globally. www.epista.com
For further information, please contact.
Vice President, Customer Operations
Epista Life Science A/S
CEO, Klavs Esbjerg
We enjoy sharing our knowledge. Get in touch to find out how Epista can add value to your Life Science company.